Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease

Clin Exp Rheumatol. 2008 Jul-Aug;26(4 Suppl 50):S133-4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Behcet Syndrome / complications
  • Behcet Syndrome / drug therapy*
  • Brain Diseases / complications
  • Brain Diseases / drug therapy*
  • Cerebrum
  • Humans
  • Infliximab
  • Male
  • Paresis / etiology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab